Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Transdermal granisetron for the prevention of chemotherapy-induced nausea and vomiting in metastatic colorectal cancer patients with high risk of bowel obstruction treated with temozolomide
Tags: chemotherapy, nausea, Sancuso®, serotonin 5-HT3 receptor antagonist, Sustol®
BASi Method Number SAP.060
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
